Characterization of [3H]quipazine binding to 5-hydroxytryptamine3 receptors in rat brain membranes.
[3H]Quipazine was used to label binding sites in rat brain membranes that display characteristics of a 5-hydroxytryptamine3 (5-HT3) receptor. The radioligand binds with high affinity (KD, 1.2 +/- 0.1 nM) to a saturable population of sites (Bmax, 3.0 +/- 0.4 pmol/g of tissue) that are differentially located in the brain. Specific [3H]quipazine binding is not affected by guanine or adenine nucleotides. ICS 205-930, BRL 43964, Lilly 278584, and zacopride display less than nanomolar affinity for these sites whereas MDL 72222 is approximately one order of magnitude less potent. The pharmacological profile of the binding site is in excellent agreement with that of 5-HT3 receptors characterized in peripheral physiological models. We conclude that [3H]quipazine labels a 5-HT3 receptor in the rat CNS.
Milburn
C M
CM
Department of Neurology, Stanford University Medical Center, California 94305.
Peroutka
S J
SJ
D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism*; D008566:Membranes / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism; D009711:Nucleotides / Q000494:pharmacology; D011804:Quinolines / Q000378:metabolism*; D011814:Quipazine / Q000378:metabolism*; D051381:Rats; D011985:Receptors, Serotonin / Q000378:metabolism*; D014316:Tritium
D018377:Neurotransmitter Agents; D009711:Nucleotides; D011804:Quinolines; D011985:Receptors, Serotonin; D014316:Tritium; D011814:Quipazine